Combating Counterfeit Pharmaceuticals Act of 2025

# Combating Counterfeit Pharmaceuticals Act of 2025 – Summary **What the Bill Would Do:** The Combating Counterfeit Pharmaceuticals Act of 2025 is designed to address the problem of fake or counterfeit medications entering the U.S. pharmaceutical supply chain. While specific details aren't available in the basic bill information, legislation with this title typically focuses on strengthening protections against counterfeit drugs through enhanced tracking, verification, and enforcement measures. **Who It Affects:** This bill would impact patients who rely on prescription medications, pharmaceutical manufacturers and distributors, healthcare providers, and regulatory agencies like the FDA.

Anyone purchasing medications could potentially benefit from improved safeguards against counterfeit products. **Current Status:** As of now, the bill (S 3134) is in committee and has not yet been voted on by the full Senate. It was introduced by Senator Tom Cotton (R-AR) in the 119th Congress. For more detailed information about the specific provisions and mechanisms proposed in the bill, the full legislative text would need to be reviewed.